These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37876102)

  • 1. Urgent need for the introduction of Tenecteplase in Pakistan: A Call to action for improved stroke and Mi Care.
    Yousaf MR; Naeem H; Shahid MB
    J Pak Med Assoc; 2023 Oct; 73(10):2139. PubMed ID: 37876102
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenecteplase for acute ischaemic stroke.
    Sandset EC; Tsivgoulis G
    Lancet; 2022 Jul; 400(10347):138-139. PubMed ID: 35779556
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis.
    Bahadori M; Mowla A
    Am J Emerg Med; 2022 May; 55():185-186. PubMed ID: 34116894
    [No Abstract]   [Full Text] [Related]  

  • 4. Tenecteplase for acute stroke: the thrombolysis puzzle.
    Coutts SB; Yu AYX
    Lancet Neurol; 2022 Jun; 21(6):496-497. PubMed ID: 35525249
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply.
    Churilov L; Bivard A; Parsons MW
    Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270302
    [No Abstract]   [Full Text] [Related]  

  • 6. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.
    Hailu K; Ragoonanan D; Davis H
    Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.
    Hanna E; Barrett TW
    Ann Emerg Med; 2023 Jun; 81(6):759-760. PubMed ID: 37210165
    [No Abstract]   [Full Text] [Related]  

  • 8. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Ferguson E; Yadav K
    CJEM; 2023 Feb; 25(2):121-122. PubMed ID: 36577932
    [No Abstract]   [Full Text] [Related]  

  • 10. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence.
    Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K
    Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase Knocking on the Door.
    Hill MD; Michel P
    Stroke; 2018 Sep; 49(9):2276-2277. PubMed ID: 30018162
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolysis with Tenecteplase in a stroke with a long time window after onset of symptoms. Report of one case].
    Montecinos C; Angel MJ; Navia V
    Rev Med Chil; 2021 Jan; 149(1):128-131. PubMed ID: 34106144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase in Acute Stroke: What About the Children?
    Sun LR; Wilson JL; Waak M; Kiskaddon A; Goldenberg NA; Jordan LC; Barry M
    Stroke; 2023 Jul; 54(7):1950-1953. PubMed ID: 37226774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Thrombolytics: from Alteplase to Tenecteplase.
    Miller SE; Warach SJ
    Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
    Ferguson E; Lang E
    Ann Intern Med; 2022 Nov; 175(11):JC124. PubMed ID: 36315948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IV tenecteplase: A non-inferior alternative to alteplase?
    Zubair AS; Sheth KN
    Med; 2022 Aug; 3(8):519-520. PubMed ID: 35963230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Coutts SB; Hill MD
    Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.